Table 1.
Facility Casemix and Other Characteristics by Network
| Network 1 n=144 | Network 2 n=187 | Network 3 n=125 | Network 4 n=206 | Network 5 n=240 | Network 6 n=445 | Network 7 n=223 | Network 8 n=273 | Network 9 n=305 | |
|---|---|---|---|---|---|---|---|---|---|
| CASEMIX* | |||||||||
| Gender (% Female) | 42.6 (37.2, 46.8) | 43.4 (37.9, 47.6) | 41.6 (37.9, 46.4) | 44.9 (39.3, 49.2) | 44.6 (39.7, 48.6) | 46.8 (42.1, 51.6) | 42.4 (37.3, 46.9) | 47.1 (41.9, 52.0) | 44.9 (39.4, 50.0) |
| Age (y) a | 65.4 (63.5, 68.7) | 64.1 (61.0, 66.5) | 63.9 (60.9, 65.9) | 64.1 (61.2, 67.1) | 61.7 (59.1, 63.8) | 59.9 (57.8, 61.7) | 62.6 (59.8, 66.9) | 60.3 (58.0, 62.4) | 63.3 (60.8, 65.2) |
| Race | |||||||||
| Caucasian | 85.0 (71.0, 93.8) | 53.3 (31.8, 77.4) | 57.6 (42.9, 75.5) | 78.8 (43.7, 94.4) | 35.8 (16.8, 59.9) | 25.5 (12.8, 40.5) | 60.3 (40.2, 75.0) | 31.1 (14.7, 60.8) | 77.4 (51.9, 92.6) |
| Black | 9.3 (3.8, 21.4) | 35.6 (17.0, 58.3) | 27.4 (9.4, 48.1) | 19.2 (4.8, 52.3) | 57.1 (31.6, 79.9) | 72.3 (54.5, 84.8) | 36.5 (20.5, 55.1) | 66.7 (35.1, 83.8) | 20.9 (5.6, 46.3) |
| Asian | 1.4 (0.0, 3.1) | 2.1 (0.5, 5.3) | 1.5 (0.0, 5.1) | 0.0 (0.0, 1.7) | 0.7 (0.0, 2.9) | 0.0 (0.0, 1.2) | 0.9 (0.0, 2.2) | 0.0 (0.0, 0.0) | 0.0 (0.0, 0.0) |
| Hispanic Ethnicity | 5.5 (0.0, 12.9) | 9.9 (3.8, 20.0) | 12.0 (6.1, 47.3) | 1.5 (0.0, 4.2) | 1.2 (0.0, 4.1) | 1.5 (0.0, 4.2) | 8.7 (3.4, 19.5) | 0.0 (0.0, 1.7) | 0.9 (0.0, 2.9) |
| Primary Cause of ESRD | |||||||||
| DM | 39.1 (33.8, 46.4) | 41.3 (34.5, 46.3) | 44.0 (38.1, 54.3) | 42.5 (35.4, 49.1) | 38.2 (33.3, 44.5) | 42.0 (35.1, 48.1) | 39.3 (34.4, 45.0) | 42.1 (35.7, 48.6) | 44.0 (37.2, 50.0) |
| HTN | 22.3 (17.0, 27.1) | 24.5 (19.3, 29.6) | 25.3 (17.8, 32.0) | 25.0 (18.8, 31.3) | 32.0 (25.0, 39.5) | 31.9 (25.3, 40.5) | 31.7 (26.6, 37.1) | 32.0 (25.9, 41.3) | 24.0 (18.1, 30.6) |
| GN | 11.3 (8.5, 13.7) | 9.4 (6.5, 12.4) | 9.0 (5.6, 11.8) | 8.8 (6.3, 12.5) | 7.6 (5.1, 10.9) | 7.7 (4.6, 11.4) | 7.9(5.4, 10.8) | 7.1 (4.0, 10.3) | 7.9 (5.0, 10.6) |
| Cystic Kidney Disease | 3.0 (1.6, 5.0) | 2.5 (1.2, 3.9) | 2.5 (1.2, 3.7) | 2.6 (0.0, 4.3) | 1.7 (0.0, 3.3) | 1.7 (0.0, 3.1) | 2.6 (1.4, 4.3) | 1.9 (0.0, 3.4) | 1.9 (0.0, 3.5) |
| Co-morbidities c | |||||||||
| PVD | 11.9 (8.5, 17.3) | 7.6 (4.6, 12.0) | 10.9 (6.1, 19.6) | 8.0 (4.3, 12.8) | 5.0 (2.6, 8.7) | 6.4 (3.4, 9.4) | 7.1 (4.1, 10.6) | 7.0 (3.5, 11.8) | 9.1 (5.2, 14.0) |
| ASHD/CAD | 22.1 (14.7, 28.2) | 18.2 (10.2, 27.2) | 20.4 (11.8, 28.1) | 14.7 (6.5, 24.0) | 7.9 (3.2, 15.5) | 8.0 (3.5, 13.2) | 9.3 (4.9, 15.5) | 11.5 (4.7, 19.2) | 14.5 (8.1, 23.5) |
| History of HTN | 63.9 (56.9, 68.2) | 60.0 (54.5, 65.4) | 63.6 (58.5, 69.0) | 60.0 (52.8, 67.4) | 57.7 (51.0, 64.5) | 60.3 (53.7, 65.7) | 57.8 (50.5, 65.0) | 61.5 (55.7, 67.3) | 63.0 (56.5, 69.0) |
| DM | 36.5 (31.4, 42.8) | 35.4 (29.0, 40.0) | 39.1 (34.7, 46.0) | 37.5 (30.0, 44.0) | 34.0 (28.3, 42.6) | 37.5 (32.0, 42.9) | 34.2 (28.4, 40.6) | 38.5 (32.4, 43.1) | 41.9 (34.5, 48.0) |
| VASCULAR ACCESS AT START OF MAINTENANCE HD* | |||||||||
| AVF Used | 18.2 (13.3, 23.3) | 12.6 (9.4, 17.6) | 12.1 (7.5, 15.7) | 12.5 (8.1, 16.2) | 10.5 (7.2, 14.3) | 11.1 (7.2, 15.0) | 8.2 (5.6, 12.7) | 10.9 (6.9, 15.3) | 11.4 (6.9, 16.2) |
| AVF Placed/Not Used | 14.1 (10.6, 19.1) | 15.4 (11.1, 20.0) | 17.2 (9.3, 26.1) | 10.7 (7.1, 14.5) | 10.3 (6.6, 14.4) | 10.8 (6.7, 15.6) | 12.3 (8.1, 18.2) | 12.8 (8.1, 17.6) | 11.8 (7.9, 17.5) |
| CVC Usedb | 48.4 (42.2, 55.2) | 50.0 (43.4, 57.1) | 56.3 (50.7, 60.2) | 55.3 (48.1, 61.8) | 52.2 (45.9, 58.1) | 49.2 (42.7, 55.6) | 53.1(46.1, 59.8) | 51.9 (44.0, 58.1) | 52.5 (45.8, 60.3) |
| OTHER** | |||||||||
| LDO | 69.4 | 36.9 | 52.0 | 76.7 | 75.0 | 77.8 | 81.6 | 85.0 | 70.6 |
| Network 10 n=149 | Network 11 n=312 | Network 12 n=196 | Network 13 n=234 | Network 14 n=341 | Network 15 n=206 | Network 16 n=124 | Network 17 n=141 | Network 18 n=206 | |
|---|---|---|---|---|---|---|---|---|---|
| CASEMIX* | |||||||||
| Gender (% Female) | 42.3 (37.5, 47.3) | 43.4 (38.5, 48.8) | 44.4 (38.5, 50.0) | 47.2 (41.0, 53.0) | 46.7 (42.9, 51.1) | 44.1 (38.6, 48.6) | 41.8 (38.0, 45.3) | 44.9 (41.4, 50.0) | 42.7 (38.7, 46.6) |
| Age a | 63.0 (60.1, 65.5) | 64.9 (61.1, 68.0) | 63.6 (60.8, 66.1) | 60.0 (58.3, 61.9) | 60.2 (58.4, 62.4) | 61.3 (58.6, 63.5) | 62.2 (60.4, 64.4) | 62.5 (60.3, 64.5) | 61.9 (59.7, 64.4) |
| Race | |||||||||
| Caucasian | 69.0 (33.3, 85.7) | 81.3 (52.8, 93.3) | 86.7 (65.3, 94.4) | 38.1 (21.3, 63.6) | 70.6 (47.0, 90.5) | 80.8 (62.8, 87.9) | 86.8 (68.5, 93.8) | 64.0 (35.5, 78.9) | 74.7 (61.2, 83.7) |
| Black | 23.4 (8.8, 61.1) | 5.8 (0.0, 34.2) | 10.7 (3.0, 31.1) | 56.4 (26.1, 76.9) | 24.6 (7.5, 48.3) | 5.6 (1.0, 13.3) | 2.7 (0.0, 7.7) | 8.3 (3.7, 20.2) | 10.3 (4.4, 23.0) |
| Asian | 0.7 (0.0, 3.4) | 0.0 (0.0, 2.9) | 0.0 (0.0, 1.7) | 0.0 (0.0, 1.2) | 0.0 (0.0, 2.0) | 1.1 (0.0, 2.7) | 2.2 (0.0, 8.8) | 13.4 (6.8, 22.2) | 6.5 (3.1, 13.3) |
| Hispanic Ethnicity | 8.2 (2.3, 16.4) | 1.9 (0.0, 5.5) | 2.4 (0.0, 5.3) | 1.6 (0.0, 4.3) | 34.7 (18.3, 72.7) | 26.7 (14.6, 46.2) | 6.7 (3.2, 12.8) | 20.5 (11.6, 32.8) | 46.6 (30.8, 58.2) |
| Primary Cause of ESRD | |||||||||
| DM | 39.4 (34.3, 45.5) | 42.9 (36.5, 48.6) | 43.5 (38.5, 50.0) | 43.4 (35.7, 50.0) | 51.4 (44.4, 62.9) | 50.7 (43.8, 58.9) | 42.2 (35.9, 50.0) | 48.6 (43.0, 56.9) | 49.1 (41.3, 55.1) |
| HTN | 30.8 (24.2, 39.4) | 23.9 (16.7, 31.4) | 25.0 (19.1, 34.5) | 33.3 (24.3, 43.8) | 24.4 (17.1, 32.4) | 18.5 (13.5, 24.0) | 18.9 (14.6, 22.8) | 21.7 (17.6, 27.7) | 27.6 (21.4, 35.0) |
| GN | 7.4 (4.7, 11.3) | 9.7 (6.1, 13.5 ) | 9.3 (5.6, 13.3) | 6.1 (3.3, 9.4) | 5.8 (3.8, 9.0) | 9.7 (5.8, 12.1) | 12.2 (8.4, 15.2) | 9.9 (7.1, 13.0) | 6.7 (4.4, 9.6) |
| Cystic Kidney Disease | 1.8 (0.0, 3.3) | 2.3 (0.0, 4.6) | 2.2 (0.0, 4.5) | 1.6 (0.0, 3.3) | 1.7 (0.0, 2.8) | 1.9 (0.0, 3.7) | 3.5 (2.0, 5.3) | 2.1 (1.0, 3.4) | 1.7 (0.9, 2.7) |
| Co-morbidities c | |||||||||
| PVD | 6.5 (3.2, 10.2) | 9.2 (5.5, 15.6) | 7.4 (3.4, 12.1) | 8.1 (4.3, 13.3) | 7.4 (3.9, 11.7) | 5.4 (2.4, 9.1) | 9.5 (7.1, 13.4) | 5.3 (3.2, 7.3) | 4.7 (2.2, 8.3) |
| ASHD/CAD | 8.7 (3.3, 17.6) | 18.7 (10.0, 26.6) | 13.2 (6.3, 21.7) | 10.7 (5.0, 18.4) | 10.5 (4.4, 18.2) | 8.4 (3.9, 14.4) | 15.8 (10.9, 22.5) | 8.0 (3.8, 14.3) | 5.7 (2.6, 11.7) |
| History of HTN | 62.1 (55.1, 68.5) | 64.9 (58.4, 71.4) | 61.2 (54.9, 67.7) | 63.3 (55.8, 69.2) | 62.1 (55.7, 67.1) | 61.5 (56.8, 67.2) | 63.3 (57.9, 68.4) | 57.9 (51.3, 63.4) | 58.5 (53.1, 63.6) |
| DM | 38.5 (31.2, 43.9) | 40.6 (33.8, 47.2) | 38.6 (31.3, 44.0) | 39.8 (33.3, 45.7) | 42.3 (36.6, 48.9) | 41.1 (35.4, 47.4) | 41.2 (35.1, 45.8) | 36.6 (32.1, 43.2) | 38.3 (32.1, 44.0) |
| VASCULAR ACCESS AT START OF MAINTENANCE HD* | |||||||||
| AVF Used | 9.4 (5.6, 14.0) | 13.0 (8.1, 18.2) | 11.1 (7.7, 17.1) | 9.8 (5.7, 14.0) | 8.6 (5.4, 12.8) | 12.4 (7.7, 16.7) | 18.4 (14.3, 21.7) | 13.4 (9.8, 17.2) | 8.0 (5.2, 12.7) |
| AVF Placed/Not Used | 9.3 (6.0, 14.3) | 11.1 (7.5, 17.3) | 13.2 (9.2, 20.0) | 9.6 (5.9, 14.3) | 12.9 (9.2, 17.1) | 12.7 (8.3, 17.7) | 12.8 (8.7, 19.1) | 12.1 (8.3, 16.7) | 8.5 (4.9, 13.4) |
| CVC Usedb | 53.7 (48.6, 59.3) | 55.3 (48.5, 60.7) | 54.5 (46.5, 60.7) | 54.4 (46.9, 62.3) | 55.1 (48.1, 61.8) | 55.8 (47.9, 62.5) | 49.0 (42.1, 55.6) | 49.4 (44.0. 55.5) | 54.1 (47.4, 59.8) |
| OTHER** | |||||||||
| LDO | 68.5 | 50.3 | 69.4 | 73.1 | 71.6 | 74.3 | 54.8 | 56.0 | 62.1 |
Note: Values shown are median (15th, 75th percentile). Categorical variables are given as percentage.
*
Source: Centers for Medicare & Medicaid Services, Standard Information Medical System, End Stage Renal Disease Medical Evidence Report Medicare Entitlement and/or Patient Registration, Form CMS-2728, January 2007 – April 2010.
**
Source: Centers for Medicare & Medicaid Services, Vascular Access Data Set as delivered by the Network Information Technology Support contractor to FFBI contractor, January 2007 – April 2010.
a
on June 1, 2010
b
with or without other access present
c
at start of maintenance hemodialysis
Abbreviations: Arteriosclerotic Heart Disease (ASHD); Arterio-venous Fistula (AVF); Coronary Artery Disease (CAD); Central Venous Catheter (CVC); GN, Glomerulonephritis; HD, hemodialysis; LDO, large dialysis organization; DM, diabetes mellitus; HTN, hypertension; Peripheral Vascular Disease (PVD)